Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ: 007370)
South Korea
· Delayed Price · Currency is KRW
6,350.00
-140.00 (-2.16%)
Jan 20, 2025, 9:00 AM KST
Jin Yang Pharmaceutical Revenue
Jin Yang Pharmaceutical had revenue of 31.62B KRW in the quarter ending September 30, 2024, with 31.36% growth. This brings the company's revenue in the last twelve months to 111.15B, up 26.58% year-over-year. In the year 2023, Jin Yang Pharmaceutical had annual revenue of 94.11B with 23.40% growth.
Revenue (ttm)
111.15B
Revenue Growth
+26.58%
P/S Ratio
0.63
Revenue / Employee
505.22M
Employees
220
Market Cap
73.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 94.11B | 17.85B | 23.40% |
Dec 31, 2022 | 76.26B | 13.43B | 21.36% |
Dec 31, 2021 | 62.84B | 13.31B | 26.88% |
Dec 31, 2020 | 49.52B | 2.17B | 4.59% |
Dec 31, 2019 | 47.35B | 488.55M | 1.04% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |